 | Up a level |
Glaus, J; von Känel, R; Lasserre, A M; Strippoli, M-P F; Vandeleur, C L; Castelao, E; Gholam-Rezaee, M; Marangoni, C; Wagner, En-Young; Marques-Vidal, P; Waeber, G; Vollenweider, P; Preisig, M; Merikangas, K R (2018). Mood disorders and circulating levels of inflammatory markers in a longitudinal population-based study. Psychological medicine, 48(6), pp. 961-973. Cambridge University Press 10.1017/S0033291717002744
Glaus, J; Vandeleur, C; Gholam-Rezaee, M; Castelao, E; Perrin, M; Rothen, S; Bovet, P; Marques-Vidal, P; von Känel, R; Merikangas, K; Mooser, V; Waterworth, D M; Waeber, G; Vollenweider, P; Preisig, M (2012). Atypical depression and alcohol misuse are related to the cardiovascular risk in the general population. Acta psychiatrica Scandinavica, 128(4), pp. 282-293. Oxford: Wiley-Blackwell
Marques-Vidal, P; Bochud, M; Bastardot, F; von Känel, R; Ferrero, F; Gaspoz, JM; Paccaud, F; Urwyler, A; Lüscher, TF; Hock, C; Waeber, G; Preisig, M; Vollenweider, P (2011). Association between inflammatory and obesity markers in a Swiss populationn-based sample (CoLaus study). Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 11 (Su(8S) Basel: EMH Editores Medicorum Helveticorum
Oneda, B; Crettol, S; Bochud, M; Besson, J; Croquette-Krokar, M; Hämmig, R; Monnat, M; Preisig, M; Eap, C B (2011). β-Arrestin2 influences the response to methadone in opioid-dependent patients. Pharmacogenomics journal, 11(4), pp. 258-66. Basingstoke: Nature Publishing Group 10.1038/tpj.2010.37
Crettol, S; Besson, J; Croquette-Krokar, M; Hämmig, R; Gothuey, I; Monnat, M; Déglon, J.J.; Preisig, M; Eap, C.B. (2008). Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment. Progress in neuro-psychopharmacology & biological psychiatry, 32(7), pp. 1722-1727. Amsterdam: Elsevier 10.1016/j.pnpbp.2008.07.009
Marques-Vidal, P; Schmid, R; Bochud, M; Bastardot, F; von Känel, R; Paccaud, F; Preisig, M; Waeber, G; Vollenweider, P (2011). Adipocytokines and inflammatory biomarkers are independent predictors of type 2 diabetes. The CoLaus study. In: Jahresversammlung Swiss Society of Endocrinology and Diabetology. Bern, Switzerland. 1./2.12.2011.
